Phase 1 single dose studies to optimize the pharmacokinetics of DG17, a novel HIV-protease inhibitor pro-drug, using sodium bicarbonate and ritonavir.

Saved in:
Bibliographic Details
Title: Phase 1 single dose studies to optimize the pharmacokinetics of DG17, a novel HIV-protease inhibitor pro-drug, using sodium bicarbonate and ritonavir.
Authors: Cherry CL; Burnet Institute, Melbourne, Australia. kcherry@burnet.edu.au, Hoy JF, Rowe JS, Krum H, Mills J, Lewin SR
Source: Current HIV research [Curr HIV Res] 2008 May; Vol. 6 (3), pp. 272-5.
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101156990 Publication Model: Print Cited Medium: Internet ISSN: 1873-4251 (Electronic) Linking ISSN: 1570162X NLM ISO Abbreviation: Curr HIV Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-4251
DOI:10.2174/157016208784324967